There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...
Herbal Transdermal Wellness Patch Category Examined as Consumers Compare Prescription GLP-1 Costs With Non-Prescription ...
A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...
The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
With changing times, the need to remain healthy and fit has become a bigger goal for many people. This goal to lose weight and become healthy is no more far-fetched now. It is something that can be ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly the problem Eli Lilly (LLY) seems to have cracked with its weight-loss pill. In a ...
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback